Clinical evaluation reveals intestinal ultrasound predicts long-term healing in Crohn's disease treated with infliximab, suggesting reliable noninvasive monitoring utility.
Baseline and postinduction IUS findings reliably predict long-term TH and MH in patients with CD receiving infliximab.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: